Sector: N/A | Industry: N/A |
See Regulatory Filings on SEC |
Company Contact | |
Address: | SUITE 550, 18500 VON KARMAN IRVINE CA 92612 |
Tel: | N/A |
Website: | https://sabrahealth.com |
IR: | See website |
Key People | ||
Richard K. Matros Chairman of the Board, President, Chief Executive Officer | Michael L. Costa Chief Financial Officer, Executive Vice President, Company Secretary | Jessica Flores Executive Vice President, Chief Accounting Officer | Talya Nevo-Hacohen Executive Vice President, Chief Investment Officer, Treasurer |
Business Overview |
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust (REIT) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment include approximately 37,834 beds/units, spread across the United States and Canada. |
Financial Overview |
For the fiscal year ended 31 December 2023, Sabra Health Care REIT Inc revenues increased 4% to $647.5M. Net income totaled $13.8M vs. loss of $77.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Loss from unconsolidated joint ventures decrease of 97% to $2.9M (expense), Impairment of real estate decrease of 85% to $14.3M (expense). |
Employees: | 48 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $5,600M as of Dec 31, 2023 |
Annual revenue (TTM): | $647.51M as of Dec 31, 2023 |
EBITDA (TTM): | $404.61M as of Dec 31, 2023 |
Net annual income (TTM): | $13.76M as of Dec 31, 2023 |
Free cash flow (TTM): | -$55.41M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $2,373M as of Dec 31, 2023 |
Shares outstanding: | 231,476,751 as of Feb 20, 2024 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |